2006 Update of the ASCO Recommendations for Antiemetics in Oncology: Guideline Summary

QualityTool

2006 Update of the ASCO Recommendations for Antiemetics in Oncology: Guideline Summary

Description

This three-page guideline summary is a 2006 update of the American Society of Clinical Oncology’s (ASCO) recommendations for the use of antiemetics in oncology.

This guideline summary addresses the following topics:

  • Chemotherapy-induced emesis
  • Radiation-induced emesis

Three tables summarize the following topics:

  • Antiemetic agents and regimens, emetic risk categories, special emetic problems, and radiation-induced emesis
  • Emetic risk of intravenously administered antineoplastic agents
  • Emetic risk of radiation regimens

A discussion, a description of the methodology, and information about additional resources are also presented.

Developer:

American Society of Clinical Oncology

Funding Sources:

American Society of Clinical Oncology

History

Release Date: 2006
Original Summary: August 2006
Last Updated: 02/16/11

QualityTool Classification

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.